Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Roberta Chaves ARAÚJO"'
Autor:
Aline Coelho Rocha Candolo, Guilherme Grossi Lopes Cançado, Patricia Momoyo Zitelli, Daniel Ferraz de Campos Mazo, Claudia Pinto Marques Oliveira, Marlone Cunha-Silva, Raquel Dias Greca, Roberta Chaves Araújo, Amanda Sacha Paulino Tolentino Alustau, Claudia Alves Couto, Mateus Jorge Nardelli, Roque Gabriel Rezende de Lima, Alberto Queiroz Farias, Flair José Carrilho, Mário Guimarães Pessôa
Publikováno v:
Gastroenterology Insights, Vol 14, Iss 4, Pp 564-574 (2023)
Background: Lysosomal acid lipase deficiency (LAL-D) is a rare genetic disease associated with the deregulation of lipid metabolism, leading to atherosclerosis, dyslipidemia, and hepatic steatosis, with potential progression to cirrhosis. Our study a
Externí odkaz:
https://doaj.org/article/412537d5d4974d84a48252290d19923f
Autor:
Guilherme Grossi Lopes Cançado, Aline Coelho Rocha Candolo, Mateus Jorge Nardelli, Patricia Momoyo Zitelli, Daniel Ferraz de Campos Mazo, Claudia Pinto Oliveira, Marlone Cunha-Silva, Raquel Dias Greca, Roberta Chaves Araújo, Amanda Sacha Paulino Tolentino Alustau, Cláudia Alves Couto, Gabriel Rezende de Lima Roque, Alberto Queiroz Farias, Flair José Carrilho, Mário Guimarães Pessôa
Publikováno v:
Frontiers in Gastroenterology, Vol 2 (2023)
IntroductionCryptogenic chronic hepatitis is a growing cause of liver transplants, affecting 5%–15% of patients with chronic liver diseases. This study aimed to identify underlying causes of cryptogenic liver disease in a Brazilian cohort and propo
Externí odkaz:
https://doaj.org/article/b580caaed9444c50ae3685f3266981f4
Autor:
Thaís Grecca Andrade, Luana Cavalcanti Dias Xavier, Fernanda Fernandes Souza, Roberta Chaves Araújo
Publikováno v:
Archives of Endocrinology and Metabolism (2022)
ABSTRACT Objective: Describe the clinical profile of patients with biopsy-proven non-alcoholic fatty liver disease (NAFLD) and analyze the risk predictors of hepatic fibrosis in outpatient follow-up at a university hospital. Subjects and methods: Dem
Externí odkaz:
https://doaj.org/article/c0484c14597f4fbeb32eff8ca51e87fa
Autor:
Aline Coelho Rocha Candolo, Patricia Momoyo Zitelli, Daniel Ferraz de Campos Mazo, Marlone Cunha-Silva, Raquel Dias Greca, Claudia Pinto de Oliveira, Roberta Chaves Araújo, Amanda Sacha Paulino Tolentino Alustau, Claudia Alves Couto, Mateus Jorge Nardelli, Júlio M. Singer, Roque Gabriel Rezende de Lima, Alberto Queiroz Farias, Flair José Carrilho, Mário Guimarães Pessoa
Publikováno v:
Annals of Hepatology, Vol 24, Iss , Pp 100495- (2021)
Background: Lysosomal acid lipase deficiency (LAL-D) is a rare genetic disease associated with lipid metabolism deregulation leading to atherosclerosis, dyslipidemia, and hepatic steatosis, with potential progression to cirrhosis. Investigation of LA
Externí odkaz:
https://doaj.org/article/ffa7a155c5f64505b9200f61b6f83bc2
Autor:
Jazon Romilson de Souza ALMEIDA, Roberta Chaves ARAÚJO, Giane Vieira de CASTILHO, Letícia STAHELIN, Lívia dos Reis PANDOLFI, Cecília Queiroz SILVA
Publikováno v:
Arquivos de Gastroenterologia, Vol 52, Iss 1, Pp 22-26 (2015)
Background Alcoholic liver disease is a major cause of end-stage liver disease worldwide and severe forms of alcoholic hepatitis are associated with a high short-term mortality. Objectives To analyze the importance of age-bilirubin-INR-creatinine (AB
Externí odkaz:
https://doaj.org/article/0441076ad0c14a68b508b6bb4c0c494e
Autor:
Roberta Chaves Araújo
Publikováno v:
Biblioteca Digital de Teses e Dissertações da USPUniversidade de São PauloUSP.
A infecção crônica pelo vírus da hepatite C (HCV) é importante fator de risco para o desenvolvimento de cirrose hepática e de carcinoma hepatocelular. A evolução para formas mais graves está relacionada a fatores ligados ao vírus, ao hosped
Autor:
Silvana Gama Florencio Chachá, João Paulo Vilela Rodrigues, Roberta Chaves Araújo, Leonardo Régis Leira Pereira, Márcia Guimarães Villanova, Fernanda Fernandes Souza, Rodrigo de Carvalho Santana, Ana de Lourdes Candolo Martinelli
Publikováno v:
Revista da Sociedade Brasileira de Medicina Tropical, Vol 51, Iss 2, Pp 146-154
Abstract INTRODUCTION: Licensed for chronic hepatitis C treatment in 2011, the protease inhibitors (PIs) telaprevir (TVR) and boceprevir (BOC), which have high sustained viral responses (SVR), ushered a new era characterized by the development of dir
Externí odkaz:
https://doaj.org/article/fc7765b196994544a338f9435ed7400b
Autor:
Oscar Corsi, Mariana Lazo, Carolina Ramírez, Ashwani K. Singal, Luis Antonio Díaz, Pedro Montes, Ramon Bataller, Juan Pablo Roblero, Juan Pablo Arab, Galo Pazmiño, Mayur Brahmania, Roberta Chaves Araújo, Luis Guillermo Toro, Manuel Mendizabal, Nelia Hernández, Eduardo Fuentes-López, Marco Arrese, Catterina Ferreccio, Andrea Márquez-Lomas, Francisco Idalsoaga, Fátima Higuera-de-la-Tijera
Publikováno v:
Hepatology (Baltimore, Md.)References. 74(5)
BACKGROUND AND AIMS Alcohol-associated liver disease (ALD) is the leading cause of liver-related mortality in Latin America, yet the impact of public health policies (PHP) on liver disease is unknown. We aimed to assess the association between alcoho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::422ce4ea1482f23dfad98cd9a69da7de
https://pubmed.ncbi.nlm.nih.gov/34134172
https://pubmed.ncbi.nlm.nih.gov/34134172
Autor:
Alvaro Urzúa, Fernando Contreras, Juan Pablo Roblero, Helena Cortez-Pinto, Douglas A. Simonetto, Aldo Torre, Vijay H. Shah, Fernando Bessone, Ramon Bataller, Michael R. Lucey, Nahum Méndez-Sánchez, Juan Carlos Restrepo, Fátima Higuera-de la Tijera, Juan G. Abraldes, Juan Pablo Arab, José Altamirano, Roberta Chaves Araújo
Publikováno v:
Annals of Hepatology, Vol 18, Iss 3, Pp 518-535 (2019)
Alcohol-related liver disease (ALD) is a major cause of advanced chronic liver disease in Latin-America, although data on prevalence is limited. Public health policies aimed at reducing the alarming prevalence of alcohol use disorder in Latin-America
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8351e962e66083f198883d1b2b828f61
http://www.sciencedirect.com/science/article/pii/S1665268119300419
http://www.sciencedirect.com/science/article/pii/S1665268119300419
Autor:
Gustavo Romero, Pierre-Emmanuel Rautou, Saba Abdulsada, Kristina R. Chacko, Roberta Chaves Araújo, Won Kim, Rohit Agrawal, Germán Soriano, Juan Pablo Arab, Inés García-Carrera, Wei Zhang, Juan Pablo Arancibia, Seth Buryska, Andreea Bumbu, Richard D. Parker, Diego Rincón, Pamela Yaquich, Alexandre Louvet, Douglas A. Simonetto, Aldo Torre, Patrick S. Kamath, Tazime Issoufaly, Susana Castro-Sanchez, Felipe Zamarripa, Juan Pablo Roblero, Manuel Mendizabal, Vijay H. Shah, Zohaib Syed Haque, Fernando Bessone, Tej I Mehta, Julio Santiago Marcelo, Ramon Bataller, Carolina A. Ramírez, Tehseen Haider, Muhammad Majeed, Virginia Clark, Veronica Prado, Natalia Baeza, Natalia Bystrianska, Prasun K. Jalal, Rakhi Maiwall, Elizabeth C. Verna, Horia Stefanescu, Michael R. Lucey, Philippe Mathurin, Patricia Guerra Salazar, Berta Cuyàs, Ana Clemente-Sanchez, Maria Laura Garrido, Maria A. Poca, Adelina Horhat, A. Rojo, Luis G. Toro, Luis Antonio Díaz, Juan Carlos Restrepo, Francisco Idalsoaga, Lubomir Skladaný, Dalia Morales-Arraez, Diego Piombino, Guadalupe Garcia-Tsao, Florencia Pollarsky, Juan G. Abraldes, Joseph C. Ahn, Jorge Arnold, María de Fátima Higuera de la Tijera, Edilmar Alvarado-Tapias, Ashwani K. Singal, Eduardo Fuentes-López, Shiv Kumar Sarin, Marcela de Sousa Coelho, Victor Vargas, Robert S. Brown, Winston Dunn, Bashar M. Attar, Joaquín Cabezas, Melisa Dirchwolf, Meritxell Ventura-Cots, Jose A Gonzalez, José Altamirano, Adrián Narvaez, P. Nagaraja Rao, Marco Arrese, Anand V. Kulkarni, Fernando Cairo
Publikováno v:
JOURNAL OF HEPATOLOGY
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Background & Aims: Corticosteroids are the only effective therapy for severe alcohol-associated hepatitis (AH), defined by a model for end-stage liver disease (MELD) score >20. However, there are patients who may be too sick to benefit from therapy.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6fbdf9f35da2ce2c87a903e66ca773a
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=4241
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=4241
